Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota.
Catheter Cardiovasc Interv. 2019 Apr 1;93(5):921-922. doi: 10.1002/ccd.28205.
Coronary artery perforation is an infrequent, but potentially life-threatening complication of percutaneous coronary intervention. There are four types of coronary perforation: (a) large vessel; (b) distal vessel; (c) septal collateral; and (d) epicardial collateral perforation. Implantation of a covered stent is the cornerstone of large vessel perforation treatment and can be used in some distal vessel perforations, when embolization is not feasible. Until now the only available covered stent in the US was the Graftmaster stent (two bare metal stents with a PTFE membrane in-between them), that has high profile and is challenging to deliver and expand. Use of the Graftmaster has been associated with high rates of in-stent restenosis and stent thrombosis. Availability of more deliverable covered stents, such as the BeGraft (Bentley InnoMed GmbH, Hechingen, Germany) and PK Papyrus (BIotronik, Lake Oswego, Oregon, that recently received FDA approval) will greatly facilitate treatment of large vessel coronary perforations.
冠状动脉穿孔是经皮冠状动脉介入治疗中一种罕见但潜在危及生命的并发症。冠状动脉穿孔有四种类型:(a) 大血管;(b) 远端血管;(c) 间隔侧支;和 (d) 心外膜侧支穿孔。覆盖支架的植入是大血管穿孔治疗的基石,在无法进行栓塞时,可以用于一些远端血管穿孔。到目前为止,美国唯一可用的覆盖支架是 Graftmaster 支架(两个裸金属支架之间有一层 PTFE 膜),它的支架轮廓高,输送和扩张都具有挑战性。使用 Graftmaster 支架与支架内再狭窄和支架内血栓形成的发生率高有关。更易输送的覆盖支架的出现,如 BeGraft(Bentley InnoMed GmbH,德国海兴根)和 PK Papyrus(BIotronik,俄勒冈州奥斯威戈湖,最近获得 FDA 批准),将极大地促进大血管冠状动脉穿孔的治疗。